- Anheuser-Busch InBev SA/NV BUD reported fourth-quarter FY22 organic sales growth of 10.2% year-on-year to $14.67 billion, missing the consensus of $15.37 billion.
- On an organic basis, total volumes declined by 0.6%, with own beer volumes down by 0.9% and non-beer volumes up by 1.9%. Revenue per hl grew 11.2%.
- The company reported a 6.6% increase in combined revenues of its global brands, Budweiser, Stella Artois, and Corona, outside of their respective home markets in 4Q22.
- Gross profit expanded 5.4% organically to $8 billion, and gross margin contracted 249 basis points to 54.6%.
- Normalized EBITDA for the quarter was $4.947 billion, with the margin contracting to 33.7%.
- Underlying EPS of $0.86 beat the consensus of $0.70.
- The company's board proposes full year 2022 dividend of €0.75 per share, subject to shareholder approval at the AGM on April 26, 2023.
- Outlook: Anheuser-Busch InBev expects its EBITDA to grow in-line with its medium-term outlook of 4%-8% and revenue to grow ahead of EBITDA from a healthy combination of volume and price.
- It sees FY23 net capital expenditure of $4.5 billion - $5 billion.
- Price Action: BUD shares are trading lower by 2.27% at $58.88 in premarket on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in